These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 36291551)

  • 1. Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension.
    Redel-Traub G; Sampson KJ; Kass RS; Bohnen MS
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel channelopathy in pulmonary arterial hypertension.
    Ma L; Roman-Campos D; Austin ED; Eyries M; Sampson KS; Soubrier F; Germain M; Trégouët DA; Borczuk A; Rosenzweig EB; Girerd B; Montani D; Humbert M; Loyd JE; Kass RS; Chung WK
    N Engl J Med; 2013 Jul; 369(4):351-361. PubMed ID: 23883380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Heterozygous
    Bohnen MS; Roman-Campos D; Terrenoire C; Jnani J; Sampson KJ; Chung WK; Kass RS
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28889099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Channelopathy Genes in Pulmonary Arterial Hypertension.
    Welch CL; Chung WK
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension.
    Le Ribeuz H; Capuano V; Girerd B; Humbert M; Montani D; Antigny F
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32882918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension.
    Cunningham KP; Holden RG; Escribano-Subias PM; Cogolludo A; Veale EL; Mathie A
    J Physiol; 2019 Feb; 597(4):1087-1101. PubMed ID: 30365877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCNK3: new gene target for pulmonary hypertension?
    Girerd B; Perros F; Antigny F; Humbert M; Montani D
    Expert Rev Respir Med; 2014 Aug; 8(4):385-7. PubMed ID: 24742047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
    Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.
    Bohnen MS; Ma L; Zhu N; Qi H; McClenaghan C; Gonzaga-Jauregui C; Dewey FE; Overton JD; Reid JG; Shuldiner AR; Baras A; Sampson KJ; Bleda M; Hadinnapola C; Haimel M; Bogaard HJ; Church C; Coghlan G; Corris PA; Eyries M; Gibbs JSR; Girerd B; Houweling AC; Humbert M; Guignabert C; Kiely DG; Lawrie A; MacKenzie Ross RV; Martin JM; Montani D; Peacock AJ; Pepke-Zaba J; Soubrier F; Suntharalingam J; Toshner M; Treacy CM; Trembath RC; Vonk Noordegraaf A; Wharton J; Wilkins MR; Wort SJ; Yates K; Gräf S; Morrell NW; Krishnan U; Rosenzweig EB; Shen Y; Nichols CG; Kass RS; Chung WK
    Circ Genom Precis Med; 2018 Oct; 11(10):e002087. PubMed ID: 30354297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
    Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
    Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of
    Lambert M; Capuano V; Boet A; Tesson L; Bertero T; Nakhleh MK; Remy S; Anegon I; Pechoux C; Hautefort A; Rucker-Martin C; Manoury B; Domergue V; Mercier O; Girerd B; Montani D; Perros F; Humbert M; Antigny F
    Circ Res; 2019 Sep; 125(7):678-695. PubMed ID: 31347976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An homozygous mutation in KCNK3 is associated with an aggressive form of hereditary pulmonary arterial hypertension.
    Navas Tejedor P; Tenorio Castaño J; Palomino Doza J; Arias Lajara P; Gordo Trujillo G; López Meseguer M; Román Broto A; Lapunzina Abadía P; Escribano Subía P
    Clin Genet; 2017 Mar; 91(3):453-457. PubMed ID: 27649371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics: Potassium channelopathy implicated in the pathogenesis of familial PAH.
    Roberts A
    Nat Rev Cardiol; 2013 Oct; 10(10):550. PubMed ID: 23939483
    [No Abstract]   [Full Text] [Related]  

  • 14. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload.
    Lambert M; Mendes-Ferreira P; Ghigna MR; LeRibeuz H; Adão R; Boet A; Capuano V; Rucker-Martin C; Brás-Silva C; Quarck R; Domergue V; Vachiéry JL; Humbert M; Perros F; Montani D; Antigny F
    Cardiovasc Res; 2021 Nov; 117(12):2474-2488. PubMed ID: 33483721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.
    Ribeuz HL; Willer AS; Chevalier B; Sancho M; Masson B; Eyries M; Jung V; Guerrera IC; Dutheil M; Jekmek KE; Laubry L; Carpentier G; Perez-Vizcaino F; Tu L; Guignabert C; Chaumais MC; Péchoux C; Humbert M; Hinzpeter A; Mercier O; Capuano V; Montani D; Antigny F
    Am J Respir Cell Mol Biol; 2024 Jul; 71(1):95-109. PubMed ID: 38546978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells.
    Le Ribeuz H; Dumont F; Ruellou G; Lambert M; Balliau T; Quatredeniers M; Girerd B; Cohen-Kaminsky S; Mercier O; Yen-Nicolaÿ S; Humbert M; Montani D; Capuano V; Antigny F
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ion channels as convergence points in the pathology of pulmonary arterial hypertension.
    Jouen-Tachoire TRH; Tucker SJ; Tammaro P
    Biochem Soc Trans; 2021 Aug; 49(4):1855-1865. PubMed ID: 34346486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium channels in pulmonary arterial hypertension.
    Boucherat O; Chabot S; Antigny F; Perros F; Provencher S; Bonnet S
    Eur Respir J; 2015 Oct; 46(4):1167-77. PubMed ID: 26341985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel channelopathy in pulmonary arterial hypertension.
    Chung WK; Sampson KS; Kass RS
    N Engl J Med; 2013 Nov; 369(22):2162. PubMed ID: 24283236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.